Axcelead DDP Enters into Drug Discovery Service Agreement with Astellas for Targeted Protein Degraders
December 26, 2024 – Axcelead Drug Discovery Partners, …
SLAS2025 International Conference & Exhibition
San Diego, CA
Identify Promising Novel Leads: Integrated HTS platform powered by computational chemistry and AI/ML
High Throughput Screening (HTS) is one of the most powerful …
Identification of covalent JNK inhibitor
The 41st Medicinal Chemistry Symposium
Identification of covalent JNK inhibitor
The 41st Medicinal Chemistry Symposium
AASLD The Liver Meeting 2024
San Diego, CA
Identify Promising Novel Leads: Axcelead’s integrated HTS platform powered by computational chemistry and AI/ML
High Throughput Screening (HTS) is one of the most powerful tools in small molecule drug discovery for identifying promising novel leads. The success of HTS depends on the design of an appropriate screening flow, the development of robust assay systems, and the availability of a high-quality compound library.
Research results of a mouse model of chronic kidney disease (AXCC mice) generated in Axcelead DDP has been published in the American Journal of Pathology as a co-authored article.
A novel deep learning approach for analyzing glomerular …